Skip to content

Intranasal Remimazolam for Premedication in Pediatric Patient

Intranasal Remimazolam for Premedication in Pediatric Patients: a Double-blinded Randomized Clinical Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04720963
Enrollment
90
Registered
2021-01-22
Start date
2021-02-07
Completion date
2022-02-28
Last updated
2023-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sedative; Anxiety Disorder

Keywords

remimazolam

Brief summary

Anesthetic inhalation induction could be one of the most stressful experiences for children during the perioperative period, with almost 50% of them showing anxiety. It is an essential challenge for pediatric anesthesiologists on how to decrease anxiety for children in the operating room (OR) environment and to facilitate a smooth induction of anesthesia. Various factors like parental separation, unfamiliar surroundings, fear of physicians and needle injections can increase their preoperative anxiety. The researchers conducted the current study to investigate whether intranasal remimazolam can reduce anxiety in children before surgery.

Detailed description

children aged 2-5 years old were randomly allocated into three equal groups based on the premedication routes: Group R with intranasal remimazolam, Group D with intranasal dexmedetomidine and Group P with intranasal placebo, respectively.

Interventions

DRUGRemimazolam

intranasal remimazolam

OTHERDistilled water for injection

intranasal distilled water for injection

DRUGDexmedetomidine

Intranasal dexmedetomidine

Sponsors

Second Affiliated Hospital of Wenzhou Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
2 Years to 5 Years
Healthy volunteers
Yes

Inclusion criteria

1. with American Society of Anesthesiologists (ASA) physical status I or II; 2. aged 2-5 years; 3. children with weight for age within the normal range 4. were scheduled surgery with general anesthesia

Exclusion criteria

1. Children who had gastrointestinal,Cardiovascular or endocrine dysfunction; 2. contraindication to preoperative sedation or had a known allergy or hypersensitive reaction to either dexmedetomidine or remimazolam; 3. with any nasal pathology,organ dysfunction; 4. recently respiratory infection, mental disorder; 5. other reasons that researchers hold it is not appropriate to participate in this trial.-

Design outcomes

Primary

MeasureTime frameDescription
The level of anxietyup to 30 minutes after study drug givenThe Modified Yale Preoperative Anxiety Scale: The 22-item measure has five behavioural categories: activity, emotional expressivity, alertness and arousal, vocalizations, and interaction with parents. Total scores range from 23.33 through 100 with higher scores indicating greater anxiety.

Secondary

MeasureTime frameDescription
the compliance of study drug givenup to 30 minutes before anesthesia inductionbehavior score 1. Clam and cooperative; 2. Anxious but reassurable; 3. Anxious but not reassurable; 4. Crying, or resisting The scores of 1 and 2 signified satisfactory compliance, whereas scores of 3 and 4 were classified as poor compliance.
Parental separation anxiety scaleup to 30 minutes after study drug givenA four-point parental separation anxiety scale as follows: 1. Easy separation, 2. Whimpers, but is easily reassured, not clinging, 3. Cries and cannot be easily reassured, but not clinging to parents, 4. Crying and clinging to parents. The scores of 1 and 2 signified acceptable separation whereas scores of 3 and 4 were classified as difficult separation.
The degree of cooperation during inhalation anesthesia inductionintraoperative, (During inhalation anesthesia induction)Induction Compliance Checklist range from 0 through 10,and lower scores indicate the higher degree of cooperation during inhalation anesthesia induction
The level of sedationup to 30 minutes after study drug givenRamsay score 1. Patient anxious or agitated or both 2. Patient cooperative, oriented and tranquil 3. Patient responds to commands only 4. A brisk response to a light glabellar tap 5. A sluggish response to a light glabellar tap 6. No response higher scores mean a higher levels of sedation.
Pediatric anesthesia emergence delirium scale,PAEDsWithin up to 15-30 minutes after child's first eye opening in the postoperative periodThe pediatric anesthesia emergence delirium scale consists of four items. Each item is scored 0-4 yielding a total between 0 and 20. The degree of emergence delirium increased directly with the total score.pediatric anesthesia emergence delirium scale ≥12 at any time indicates presence of emergence delirium.
Recovery timesWithin up to 30 minutes after child's first eye opening in the postoperative periodThe time from discontinuation of sevoflurane to the first open eye of the children and to achieve aldrete≥9
Number of children with adverse effectsUp to 24 hours including preoperative, intraoperative, and postoperative periodsNumber of children with adverse effects 1. Bradycardia and/or hypotension need for hemodynamic support 2. Desaturation is defined as Oxygen desaturation \<90% 3. Any adverse effects requiring interventions
Mask acceptance scale,MASintraoperative, (During inhalation anesthesia induction)Mask acceptance scale,MAS 1. terrified, crying, agitated 2. moderate fear, not calmed with reassurance 3. slight fear of mask, easily calmed 4. unafraid, cooperative, accepts mask readily The scores of 3 and 4 signified satisfactory mask acceptable whereas scores of 1 and 2 were classified as poor mask acceptable.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026